ElevateBio

Overview

ElevateBio is an advanced therapies CDMO specializing in the development and manufacturing of cell and gene therapies to address rare disease and cancer. The company partners with innovators across the full development journey, from early discovery and process development through technology transfer, clinical supply, and commercial cGMP manufacturing.

Core Capabilities

Discovery & Optimization

• Gene editing tools and discovery services
• Candidate discovery, engineering, and proof of concept
• Clinical lead optimization
• AI-assisted protein engineering

Process Development & Manufacturing

• Process development, optimization, characterization, and verification
• Preclinical and Phase 1 manufacturing
• Late-stage and pivotal manufacturing
• Commercial-scale manufacturing
• Technology transfer with dedicated teams

Analytical & Quality Services

• Analytical development including assay development, characterization, and validation
• Next-generation sequencing and rapid analytics
• Lot release testing
• Custom assays and testing strategies for regulatory filings

Regulatory Support

• CMC regulatory strategy from IND through BLA
• Process performance qualification (PPQ)
• Inspection readiness and BLA filing support
• Product licensing inspection support
• Manufacturing optimization

Modalities Supported

• Cell therapies
• Viral vectors
• mRNA therapeutics and vaccines
• Gene editing

Differentiation

ElevateBio emphasizes integrated operations with science, process development, manufacturing, and quality under one roof to eliminate handoffs and delays. The company invests continuously in automation, AI-assisted design, and process innovation. Processes are designed to scale from development through commercial manufacturing without compromising efficiency or cost.